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Dissociable cognitive impairments 
in two strains of transgenic 
Alzheimer’s disease mice revealed 
by a battery of object-based tests
Samantha D. Creighton1, Ari L. Mendell2, Daniel Palmer1, Bettina E. Kalisch2, 
Neil J. MacLusky2, Vania F. Prado3,4,5, Marco A. M. Prado  3,4,5 & Boyer D. Winters1
Object recognition tasks detect cognitive deficits in transgenic Alzheimer’s disease (AD) mouse models. 
Object recognition, however, is not a unitary process, and there are many uncharacterized facets of 
object processing with relevance to AD. We therefore systematically evaluated object processing in 
5xFAD and 3xTG AD mice to clarify the nature of object recognition-related deficits. Twelve-month-old 
male and female 5xFAD and 3xTG mice were assessed on tasks for object identity recognition, spatial 
recognition, and multisensory object perception. Memory and multisensory perceptual impairments 
were observed, with interesting dissociations between transgenic AD strains and sex that paralleled 
neuropathological changes. Overreliance on the widespread “object recognition” task threatens 
to slow discovery of potentially significant and clinically relevant behavioural effects related to this 
multifaceted cognitive function. The current results support the use of carefully designed object-based 
test batteries to clarify the relationship between “object recognition” impairments and specific aspects 
of AD pathology in rodent models.
Alzheimer’s disease (AD) is a neurodegenerative disorder characterized by cognitive dysfunction, as well as 
pathological accumulation of amyloid-β (Aβ) and hyperphosphorylated tau1. Transgenic mouse models of AD 
that express familial AD mutations recapitulate key features of Aβ and tau pathology and provide valuable insight 
into molecular and behavioural abnormalities in AD patients. 5xFAD transgenic mice express three mutations in 
the APP gene (K670N/M671L, I716V, and V717I) and two mutations in the PS1 gene (M146L and L286V), which 
induces aggressive amyloid pathology and neuronal loss2. 3xTG transgenic mice express APP (K670N/M671L) 
and PS1 (M146V) mutations associated with amyloid pathology in addition to a human tauopathy mutation 
(tauP301L)3. Because 5xFAD and 3xTG models have distinct neuropathological features and staging, comparing 
these complementary AD models could help clarify behavioural deficits associated with specific elements of AD 
pathology.
Object recognition (OR) is a rodent analogue of visual recognition memory tests in which human AD patients 
are impaired2,3. Rodent OR tasks have great translational potential because extensive training, reward and expo-
sure to aversive stimuli are not required, and their one-trial nature is analogous to human episodic memory. 
Several studies have demonstrated OR memory deficits in 5xFAD4–9 and 3xTG mice10–24. However, the specific 
nature of OR deficits remains somewhat unclear, as some studies have failed to report OR impairments8,13,17,25–29. 
Differential performance on OR tasks is likely due to the lack of a standardized OR paradigm and systematic eval-
uation of sex, age and mnemonic delay. Furthermore, procedural differences can alter the conceptual nature of the 
task and thus tax distinct behavioural processes. Indeed, there are also many specific facets of object information 
processing that are affected by AD neuropathology in human patients. For example, AD patients have impaired 
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spatial processing30, as well as multisensory integration and perception deficits31,32. While studies have described 
deficits in object spatial processing in transgenic AD mice33, multisensory integration has yet to be evaluated.
Here, we used a battery of specifically-designed cognitive tests to perform a systematic analysis of object pro-
cessing in 12-month-old male and female 5xFAD and 3xTG mice to clarify the relationship between pathology 
and behavioural deficits across strains of AD mice. We report multifaceted impairment in object processing, 
with interesting strain and sex differences in object identity memory (OR), spatial memory (object location; OL), 
and multisensory perceptual integration (multisensory object oddity; MSO) that correspond with pathological 
changes in Aβ42, phosphorylated tau (P-tau) and other proteins associated with AD pathology.
Results
Object-based Memory Tasks. To specifically evaluate object identity processing, 5xFAD and 3xTG 
mice were tested using the Y-apparatus, which minimizes contextual cues. Y-apparatus OR was impaired in a 
delay-independent manner in 5xFAD mice (2 × 2 × 2 split-plot ANOVA: genotype (F1,36 = 19.198, p < 0.001), 
delay (F1,36 = 9.560, p = 0.004), and genotype x delay (F1,36 = 8.563; p = 0.006); Fig. 1d). Paired sample t-tests 
between sample and choice DR suggest intact memory in Wt males and Wt females at 5 min (Wt males, 5 min: 
t10 = −3.253, p = 0.009; Wt males, 3 h: t10 = −2.787, p = 0.019; Wt females, 5 min: t7 = −6.195, p < 0.001), but 
impaired memory in Wt females at 3 h (although approaching statistical significance; t7 = 2.071, p = 0.054), and 
5xFAD mice in all conditions, as they failed to discriminate between the novel and sample objects (5xFAD males, 
5 min: t9 = −2.062, p = 0.069 (although approaching significance); 5xFAD males, 3 h: t9 = 1.009, p = 0.339; 5xFAD 
females, 5 min: t10 = −0.407, p = 0.692; 5xFAD females, 3 h: t10 = 0.870, p = 0.405). 3xTG mice, however, were 
impaired in a delay-dependent manner (2 × 2 × 2 split-plot ANOVA: genotype (F1,36 = 26.260, p < 0.001), delay 
(F1,36 = 19.172, p < 0.001), and genotype x delay (F1,36 = 21.012, p < 0.001); Fig. 1g). Paired samples t-tests indi-
cated intact memory in Wt mice (Wt males, 5 min: t10 = −4.453, p = 0.001; Wt males, 3 h: t10 = −6.851, p < 0.001; 
Wt females, 5 min: t11 = −4.013, p = 0.002; Wt females, 3 h: t11 = −6.851, p < 0.001), and 3xTG mice at 5 min 
(3xTG males: t6 = −4.321, p = 0.005; 3xTG females: t9 = −8.264, p < 0.001), but impaired memory in 3xTG mice 
at 3 h, as they failed to distinguish significantly between novel and sample objects (3xTG males: t6 = −0.135, 
p = 0.897; 3xTG females: t9 = 0.963, p = 0.361).
We also evaluated OR in 5xFAD and 3xTG mice using a standard open-field, where spatial information is 
readily available. 5xFAD mice were also delay-independently impaired on open-field OR (2 × 2 × 2 split-plot 
ANOVA: genotype (F1,32 = 6.392, p = 0.017), delay (F1,32 = 22.725, p < 0.001), and genotype × delay (F1,32 = 7.791, 
p = 0.009); Fig. 1e). Paired samples t-tests between sample and choice DR indicated intact memory in Wt mice 
(Wt males, 5 min: t10 = −6.219, p < 0.001; Wt males, 3 h: t10 = −4.346, p = 0.002; Wt females, 5 min: t7 = −4.657, 
p = 0.002; Wt females, 3 h: t7 = −3.928, p = 0.006), but impaired memory in 5xFAD mice in all conditions, as they 
failed to distinguish significantly between novel and sample objects (5xFAD males, 5 min: t9 = −2.070, p = 0.068 
(although approaching statistical significance); 5xFAD males, 3 h: t10 = t9 = −0.415, p = 0.689; 5xFAD females, 
5 min: t10 = −0.668, p = 0.519; 5xFAD females, 3 h: t10 = 0.335, p = 0.746). Open-field OR was also impaired 
in 3xTG mice, as females and males were delay-dependently and delay-independently impaired, respectively 
(2 × 2 × 2 split-plot ANOVA: genotype (F1,36 = 26.260, p < 0.001), delay (F1,36 = 19.172, p < 0.001), and gen-
otype × delay (F1,36 = 21.012, p < 0.001); Fig. 1h). Paired samples t-tests indicated intact memory in Wt mice 
(Wt males, 5 min: t10 = 3.918, p = 0.001; Wt males, 3 h: t10 = 3.000, p = 0.008; Wt females, 5 min: t11 = −7.094, 
p < 0.001; Wt females, 3 h: t11 = 4.835, p = 0.001) and 3xTG females at 5 min (3xTG females: t9 = −4.096, 
p = 0.003), but impaired memory in 3xTG males at both delays (5 min: t6 = −0.413, p = 0.694; 3 h: t6 = 0.708, 
p = 0.505), and 3xTG females at 3 h (t9 = −1.230, p = 0.250).
To evaluate spatial object processing directly, 5xFAD and 3xTG mice were tested on the OL task. 5xFAD mice 
had impaired spatial memory at both 5 min and 3 h delays (2 × 2 × 2 split-plot ANOVA: genotype (F1,43 = 20.451, 
p < 0.001); Fig. 1f). Paired samples t-tests between sample and choice DR indicated intact memory in Wt mice 
(Wt males, 5 min: t14 = −4.115, p = 0.001; Wt males, 3 h: t14 = −6.771, p < 0.0001; Wt females, 5 min: t11 = −4.013, 
p = 0.002; Wt females, 3 h: t11 = −2.663, p = 0.026), but impaired memory in 5xFAD mice in all conditions 
(5xFAD males, 5 min: t9 = −0.228, p = 0.825; 5xFAD males, 3 h: t9 = 0.200, p = 0.846; 5xFAD females, 5 min: 
t9 = 0.522, p = 0.613; 5xFAD females, 3 h: t9 = 0.200, p = 0.846). Similarly, OL was delay-independently impaired 
in 3xTG mice (2 × 2 × 2 split-plot ANOVA: genotype (F1,51 = 43.417, p < 0.001), and delay (F1,51 = 16.387, 
p < 0.001); Fig. 1i). Paired samples t-tests suggest intact memory in Wt females and Wt males at 5 min (Wt 
males, 5 min: t11 = −3.850, p = 0.002; Wt females, 5 min: t14 = −5.264, p < 0.001; Wt females, 3 h; t14 = 10.856, 
p < 0.001), but impaired memory in Wt males at 3 h and 3xTG mice in all conditions (Wt males, 3 h: t11 = 1.978, 
p = 0.076 (although approaching significance); 3xTG males, 5 min: t13 = −1.251, p = 0.233; 3xTG females, 5 min: 
t14 = −1.149, p = 0.271; 3xTG females, 3 h: t14 = −0.576, p = 0.575). 3xTG males displayed a familiarity preference 
at 3 h (t13 = 2.518, p = 0.027), instead of the novelty preference from which rodent object memory is typically 
inferred. A familiarity preference may imply intact memory, and could reflect abnormities in habituation, dis-
habituation or novelty preference. However, given the impairment observed at the 5-min delay, in this case it is 
possible that the familiarity preference is the result of a sample DR greater than zero. Indeed, a single-sample t-test 
comparing the 3xTG male choice DR at 3 h to 0 was not significant (t13 = −2.103, p = 0.06).
Perceptual Object Oddity Tasks. Finally, object oddity tasks were used to evaluate multisensory integra-
tion, as well as unimodal tactile and visual object perception. Wt males and 5xFAD mice had irregular perfor-
mance on object oddity (2 × 2 × 3 split-plot ANOVA: task (F2,78 = 3.740, p = 0.035) and task × sex (F2,78 = 4.302, 
p = 0.022); Fig. 2b). One-sample t-tests suggested intact perception in Wt females and Wt males (Wt male, visual: 
t9 = 2.749, p = 0.023; Wt female, MSO: t9 = 6.018, p < 0.001; Wt female, visual: t9 = 4.4092, p = 0.003; Wt female, 
tactile: t9 = 3.062, p = 0.014), with the exception of Wt males on the MSO and tactile tasks (Wt male, MSO: 
t9 = −0.409, p = 0.692; Wt male, tactile: t9 = 2.123, p = 0.066 (although approaching statistical significance)). 
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5xFAD female mice had intact unimodal perception (visual: t10 = 3.366, p = 0.007; tactile: t10 = 4.502, p = 0.001), 
but not MSO (t10 = −0.058, p = 0.955). 5xFAD males had impaired perception on all tasks (MSO: t11 = −1.978, 
p = 0.073 (although approaching significance); visual: t11 = 1.619, p = 0.134; tactile: t11 = 1.127, p = 0.286). 
3xTG mice demonstrated a selective impairment in tactile-visual multisensory perception, while unimodal 
tasks were generally unimpaired (2 × 2 × 3 split-plot ANOVA: task (F2,104 = 4.795, p = 0.010) and task x geno-
type (F1,104 = 6.967, p = 0.001); Fig. 2c). One-sample t-tests demonstrated perception above chance in Wt mice 
(males, MSO: t12 = 4.572, p = 0.001; males, tactile; t12 = 4.535, p = 0.001; females, MSO: t14 = 5.333, p < 0.001; 
females, visual: t14 = 5.627, p < 0.001; females, tactile: t14 = 6.460, p < 0.001), with the exception of visual percep-
tion in Wt males (visual: t12 = 1.274, p = 0.220). 3xTG mice had intact perception (3xTG males, visual: t13 = 3.609, 
p = 0.003; 3xTG males, tactile: t13 = 5.065, p < 0.001; 3xTG females, visual: t13 = 4.027, p = 0.001; 3xTG females, 
tactile t13 = 3.788, p = 0.002), except on the MSO task (males: t13 = 0.401, p = 0.695; females: t13 = 2.156, p = 0.050 
(although very close to significance)).
Figure 1. 5xFAD and 3xTG mice have impairments in object-based memory tasks. Schematic representations 
of the (a) Y-apparatus OR, (b) open-field OR, and (c) OL tasks. (d) 5xFAD mice were impaired on Y-apparatus 
OR (Wt male n = 11, Wt female n = 8, 5xFAD male n = 10, 5xFAD female n = 11; significant main effects 
of genotype (F1,36 = 19.198, p < 0.001) and delay (F1,36 = 9.560, p = 0.004), as well as a genotype x delay 
interaction (F1,36 = 8.563; p = 0.006) were observed), (e) open-field OR (Wt male n = 11, Wt female n = 8, 
5xFAD male n = 10, 5xFAD female n = 11; significant main effects of genotype (F1,32 = 6.392, p = 0.017) and 
delay (F1,32 = 22.725, p < 0.001), as well as a genotype x delay interaction (F1,32 = 7.791, p = 0.009) were found) 
and (f) OL (Wt male n = 15, Wt female n = 12, 5xFAD male n = 10, 5xFAD male n = 10; a significant main 
effect of genotype was found (F1,43 = 20.451, p < 0.001) at both 5 min and 3 h retention delays. 3xTG mice 
had more selective memory impairments. (g) 3xTG mice were impaired on Y-apparatus OR at the 3 h, but 
not 5 min, delay (Wt male n = 11, Wt female n = 12, 3xTG male n = 7, 3xTG female n = 10; significant main 
effects of genotype (F1,36 = 26.260, p < 0.001) and delay (F1,36 = 19.172, p < 0.001), as well as a genotype x delay 
interaction (F1,36 = 21.012, p < 0.001) were observed). (h) 3xTG males were impaired on open-field OR at 
both the 5 min and 3 h delays, whereas females were only impaired at the 3 h delay (Wt male n = 11, Wt female 
n = 12, 3xTG male n = 7, 3xTG female n = 12; significant main effects of genotype (F1,36 = 26.260, p < 0.001) 
and delay (F1,36 = 19.172, p < 0.001), as well as a genotype x delay interaction (F1,36 = 21.012, p < 0.001) were 
demonstrated). (i) 3xTG mice were also impaired on OL at both delays (Wt male n = 12, Wt female n = 15, 
3xTG male n = 14, 3xTG female n = 15; significant main effects of genotype (F1,51 = 43.417, p < 0.001) and 
delay (F1,51 = 16.387, p < 0.001) were found).Data are mean discrimination ratio ± SEM. *p < 0.05, **p < 0.01, 
***p < 0.001 indicates significant differences between sample and choice DR, suggesting intact memory 
(paired-sample t-tests, two-tailed). ††p < 0.01, †††p < 0.001 indicates a significant overall difference between Wt 
and 5xFAD or 3xTG mice (independent samples t-test, two-tailed, Bonferroni correction).
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Figure 2. 5xFAD and 3xTG mice have impairments in multisensory object oddity. (a) Schematic of 
multisensory and unimodal object oddity tasks. Wt and 5xFAD male mice had irregular performance on 
multisensory and unimodal tactile and visual object oddity. (b) 5xFAD female mice had a deficit in multisensory 
but not unimodal tactile or visual oddity (Wt male n = 10, Wt female n = 10, 5xFAD male n = 12, 5xFAD female 
n = 11; a significant main effect of task (F2,78 = 3.740, p = 0.035) and a task x sex interaction (F2,78 = 4.302, 
p = 0.022) were observed). (c) 3xTG mice had deficits in multisensory but not unimodal tactile or visual object 
oddity (Wt male n = 13, Wt female n = 15, 3xTG male n = 14, 3xTG female n = 14; a significant main effect of 
task (F2,104 = 4.795, p = 0.010) and task x genotype interaction (F1,104 = 6.967, p = 0.001) were found). Data are 
mean oddity preference ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001 indicates significant one-sample t-tests, 
suggesting intact perception (two-tailed). †††p < 0.001 Indicates a significant difference between Wt and 3xTG 
mice (independent samples t-test, two-tailed, Bonferroni correction). ‡‡p < 0.01 Indicates a significant difference 
between males and females (independent samples t-test, two-tailed, Bonferroni correction).
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ELISA. 5xFAD mice have extensive Aβ42 deposition in the cortex and HPC (2 × 2 × 2 ANOVA: genotype 
(F1,24 = 632.278, p < 0.0001), sex (F1,24 = 20.770, p < 0.0001), brain region (F1,24 = 147.648, p < 0.0001), geno-
type x brain region (F1,24 = 147.648, p < 0.0001), and genotype × sex (F1,24 = 20.770, p < 0.0001); Fig. 3a). Note: 
Aβ42 was undetectable in all Wt samples (<10 pg/mL); values of 0 were assigned to undetectable samples for 
analyses. Only 3xTG female mice demonstrate sizeable Aβ42 deposition in the HPC (2 × 2 × 2 ANOVA: gen-
otype (F1,28 = 17.329, p < 0.0001), sex (F1,28 = 25.974, p < 0.0001), brain region (F1,28 = 10.650, p = 0.003), gen-
otype × sex (F1,28 = 20.093, p < 0.0001), genotype x brain region (F1,28 = 20.093, p < 0.0001), sex × brain region 
(F1,28 = 20.093, p < 0.001), and genotype x sex x brain region (F1,28 = 16.816, p < 0.0001); Fig. 3b). Independent 
samples t-tests revealed significantly higher Aβ42 levels in the 3xTG female HPC than the Wt HPC (t8 = −5.222, 
p < 0.0001) and 3xTG female cortex (t8 = 4.624, p = 0.001). Note: Aβ42 was undetectable (<1 pg/mL) in 4 Wt 
male HPC samples, 4 Wt female HPC samples, 2 3xTG male cortical samples, 1 3xTG female cortical sample, 
and two 3xTG male HPC samples. Although significant Aβ42 was undetectable by ELISA in 3xTG males, total 
Figure 3. Aβ42 deposition in 13 month old 5xFAD and 3xTG mice. (a) There is extensive Aβ42 accumulation 
in the cortex and HPC of 5xFAD mice (n = 4 per group; main effects of genotype (F1,24 = 632.278, p < 0.0001), 
sex (F1,24 = 20.770, p < 0.0001), brain region (F1,24 = 147.648, p < 0.0001), as well as genotype x brain region 
(F1,24 = 147.648, p < 0.0001), and genotype × sex (F1,24 = 20.770, p < 0.0001) interactions were observed). (b) 
Only 3xTG female mice demonstrate sizeable Aβ42 deposition in the HPC (male n = 4 per group, female n = 5 
per group; significant main effects of genotype (F1,28 = 17.329, p < 0.0001), sex (F1,28 = 25.974, p < 0.0001), 
brain region (F1,28 = 10.650, p = 0.003), as well as genotype x sex (F1,28 = 20.093, p < 0.0001), genotype x brain 
region (F1,28 = 20.093, p < 0.0001), sex x brain region (F1,28 = 20.093, p < 0.001), and genotype x sex x brain 
region (F1,28 = 16.816, p < 0.0001) interactions were observed). Total Aβ (37, 38, 39, 40, 42), however, could be 
detected in both (c) 5xFAD and (d) 3xTG mice, above Wt levels, using western blotting. ELISA data are mean 
Aβ42 pg/ug protein ± SEM. †††p < 0.001 Indicates a significant difference between Wt and 5xFAD or 3xTG mice 
(independent samples t-test, two-tailed, Bonferroni correction).
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Aβ (37,38,39,40,42) could be detected in both 3xTG females and males, above Wt levels, using western blotting 
(Fig. 3d). Densitometry was not performed because Aβ was undetectable in Wt samples.
Western Blots. Aged 5xFAD and 3xTG mice have several significant changes to a number of proteins asso-
ciated with AD pathology.
5xFAD mice have abnormal expression of P-tau Ser202, P-tau Ser396, PSD-95, NeuN, GFAP, and ChAT, 
relative to Wt, in the cortex (2 × 2 ANOVA: P-tau Ser202 genotype (F1,16 = 5.633, p = 0.035); P-tau Ser396 sex 
(F1,16 = 5.635, p = 0.035), genotype x sex (F1,16 = 4.770, p = 0.050); PSD-95 sex (F1,16 = 9.742, p = 0.009); NeuN 
sex (F1,16 = 6.702, p = 0.024), genotype x sex (F1,16 = 7.344, p = 0.019); GFAP genotype (F1,16 = 48.595, p < 0.0001), 
sex (F1,16 = 13.261, p = 0.003), genotype x sex (F1,16 = 13.995, p = 0.003); ChAT genotype (F1,16 = 6.432, p = 0.026), 
sex (F1,16 = 5.954, p = 0.031), genotype x sex (F1,16 = 5.612, p = 0.035) Fig. 4b) and/or HPC (2 × 2 ANOVA: P-tau 
Ser202 genotype F1,16 = 143.914, p < 0.0001; GFAP genotype (F1,16 = 100.387, p < 0.0001), sex (F1,16 = 5.095, 
p = 0.043), genotype x sex (F1,16 = 5.090, p = 0.044); ChAT genotype (F1,16 = 7.109, p = 0.021) Fig. 4c)). 
Independent samples t-tests revealed a significant difference between cortical levels of P-tau Ser396 (t6 = 3.685, 
p = 0.010), PSD-95 (t6 = −4.206, p = 0.006), NeuN (t6 = −3.810, p = 0.009), and GFAP (t6 = −4.460, p = 0.004). 
There was also a significant difference between hippocampal levels of P-tau Ser396 in 5xFAD males and females 
(t6 = −5.117, p = 0.002). Independent samples t-tests revealed a significant difference between cortical levels of 
NeuN (t6 = 5.278, p = 0.002) in Wt and 5xFAD males. There was also a significant difference between Wt and 
5xFAD levels of GFAP in the cortex (males: t6 = −4.930, p = 0.003; females: t6 = −5.669, p = 0.001) and HPC 
(males: t6 = −5.855, p = 0.001; females: t6 = −8.198, p < 0.0001).
3xTG mice have abnormal protein expression of phospho-tau (Ser202, Ser396 and total Tau5), PSD-95, 
NeuN, GFAP and ChAT in the cortex (2 × 2 ANOVA: P-tau Ser202 genotype (F1,18 = 25.208, p < 0.0001); P-tau 
Ser396 genotype (F1,18 = 6.794, p = 0.021), sex (F1,18 = 5.855, p = 0.030), genotype x sex (F1,18 = 6.103, p = 0.027); 
PSD-95 sex (F1,18 = 5.876, p = 0.029), genotype x sex (F1,18 = 4.894, p = 0.044); NeuN genotype (F1,18 = 5.179, 
p = 0.039); GFAP sex (F1,18 = 10.885, p = 0.005), genotype x sex (F1,18 = 10.434, p = 0.006); Fig. 5b) and/or HPC 
(2 × 2 ANOVA: P-tau Ser202 genotype (F1,18 = 77.628, p < 0.0001); tau5 genotype (F1,18 = 35.523, p < 0.0001); 
Figure 4. 13 month old 5xFAD mice have abnormal expression of phospho-tau (Ser202, Ser396), PSD-95, 
NeuN, GFAP, and ChAT in the cortex and/or HPC. (a) Representative western blots (n = 4 per group). The 
approximate molecular weights for each identified protein, in kilodaltons (kDa) are shown to the right of the 
bands. Corresponding densitometric measurement in the (b) cortex (P-tau Ser202 genotype (F1,16 = 5.633, 
p = 0.035); P-tau Ser396 sex (F1,16 = 5.635, p = 0.035), genotype × sex (F1,16 = 4.770, p = 0.050); PSD-95 sex 
(F1,16 = 9.742, p = 0.009); NeuN sex (F1,16 = 6.702, p = 0.024), genotype x sex (F1,16 = 7.344, p = 0.019); GFAP 
genotype (F1,16 = 48.595, p < 0.0001), sex (F1,16 = 13.261, p = 0.003), genotype x sex (F1,16 = 13.995, p = 0.003); 
ChAT genotype (F1,16 = 6.432, p = 0.026), sex (F1,16 = 5.954, p = 0.031), genotype × sex (F1,16 = 5.612, p = 0.035) 
and (c) HPC (P-tau Ser202 genotype F1,16 = 143.914, p < 0.0001; GFAP genotype (F1,16 = 100.387, p < 0.0001), 
sex (F1,16 = 5.095, p = 0.043), genotype x sex (F1,16 = 5.090, p = 0.044); ChAT genotype (F1,16 = 7.109, p = 0.021). 
All values for 5xFAD mice are presented as a fold change in band intensity relative to Wt mice on the same 
blot; therefore, all Wt values are presented with a mean of 1. Data are mean expression ± SEM. ††p < 0.01 
Indicates a significant difference between Wt and 5xFAD (independent samples t-test, two-tailed, Bonferroni 
correction). ‡p < 0.05 Indicates a significant difference between males and females (independent samples t-test, 
two-tailed, Bonferroni correction). Blots have been cropped for conciseness; full length blots are presented in 
Supplementary Figures 1–4.
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GFAP genotype (F1,18 = 23.200, p < 0.0001), sex (F1,18 = 7.261, p = 0.017), genotype x sex (F1,18 = 7.210, p = 0.018); 
ChAT sex (F1,18 = 6.468, p = 0.023), genotype x sex (F1,18 = 6.142, p = 0.027); Fig. 5c). Independent samples t-tests 
revealed significant differences between cortical GFAP levels in Wt and 3xTG males (t6 = −3.561, p = 0.012), as 
well as male and female 3xTG mice (t6 = 4.394, p = 0.003). There was also a significant difference between hip-
pocampal levels of GFAP in Wt and 3xTG females (t6 = −5.502, p = 0.001), as well as male and female 3xTG mice 
(t6 = −4.409, p = 0.003).
Discussion
This study demonstrates impairments in object memory and perception in male and female 5xFAD and 3xTG 
mice, and these deficits parallel AD-like pathological changes. Specifically, tasks that directly probe different 
aspects of object processing (object identity memory, spatial location memory, and perceptual discrimination) 
reveal distinctive patterns of impairment in different strains and sexes. The pattern of impairments we observed 
in 5xFAD and 3xTG mice are consistent with both the large literature demonstrating impairments in AD mice4–24, 
as well as the lack of impairments8,13,17,25–29 seen in some studies which have used short retention delays or 
younger animals.
Object recognition impairments in 5xFAD and 3xTG mice were observed in both the Y-apparatus and 
open-field tasks. 5xFAD mice had OR impairments at the 5-min and 3-h retention delays, although a few 5xFAD 
groups appeared to be trending towards statistical limits that would demonstrate intact memory. The wide-
spread impairments observed in 5xFAD mice are consistent with their severe pathology and possibly indicate the 
presence of attentional deficits in addition to memory impairment. 3xTG mice had selective impairments in 
Y-apparatus OR at 3 h, suggestive of a more selective long-term object memory deficit. However, when OR was 
evaluated in the open-field, 3xTG females were also selectively impaired at 3 h but 3xTG males were impaired at 
both 5 min and 3 h. This suggests that OR impairments can become more severe in some strains when the spatial 
nature of the task is increased. The Y-apparatus could increase the focus on objects and provides fewer potentially 
interfering contextual stimuli than the open-field. Perhaps AD mice have insufficient mnemonic resources for 
both object and environmental information present in the open-field OR task. While the HPC seems to be nec-
essary for basic OR in mice34,35, the open-field OR task likely places even greater demand on the HPC36,37, which 
has substantial amyloid accumulation.
Figure 5. 13 month old 3xTG mice have abnormal protein expression of phospho-tau (Ser202, Ser396 and 
total Tau5), PSD-95, NeuN, GFAP and ChAT in the cortex and/or HPC. (a) Representative western blots (male 
n = 4 per group, female n = 5 per group). Corresponding densitometric measurement in the (b) cortex (P-tau 
Ser202 genotype (F1,18 = 25.208, p < 0.0001); P-tau Ser396 genotype (F1,18 = 6.794, p = 0.021), sex (F1,18 = 5.855, 
p = 0.030), genotype x sex (F1,18 = 6.103, p = 0.027); PSD-95 sex (F1,18 = 5.876, p = 0.029), genotype x sex 
(F1,18 = 4.894, p = 0.044); NeuN genotype (F1,18 = 5.179, p = 0.039); GFAP sex (F1,18 = 10.885, p = 0.005), 
genotype x sex (F1,18 = 10.434, p = 0.006) and (c) HPC (P-tau Ser202 genotype (F1,18 = 77.628, p < 0.0001); tau5 
genotype (F1,18 = 35.523, p < 0.0001); GFAP genotype (F1,18 = 23.200, p < 0.0001), sex (F1,18 = 7.261, p = 0.017), 
genotype × sex (F1,18 = 7.210, p = 0.018); ChAT sex (F1,18 = 6.468, p = 0.023), genotype × sex (F1,18 = 6.142, 
p = 0.027). All values for 3xTG mice are presented as a fold change in band intensity relative to Wt mice on the 
same blot; therefore, all Wt values are presented with a mean of 1. Data are mean expression ± SEM. ††p < 0.01 
Indicates a significant difference between Wt and 3xTG (independent samples t-test, two-tailed, Bonferroni 
correction). ‡p < 0.05 Indicates a significant difference between males and females (independent samples t-test, 
two-tailed, Bonferroni correction). Blots have been cropped for conciseness; full length blots are presented in 
Supplementary Figures 5–8.
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In OR, we also observed a subtle sex difference between 3xTG males and females, where 3xTG females had a 
less severe OR deficit than males. Specifically, short-term OR memory was intact in 3xTG females in open-field 
and Y-apparatus OR, whereas 3xTG males had short-term open-field OR deficits that were not observed at short 
retention delays in the Y-apparatus. This pattern is consistent with sexual dimorphism in working memory, such 
that 3xTG males have a more severe behavioural deficit beginning at two-months-of-age38. Although our data, 
and others39–41, demonstrate a more aggressive amyloid pathology in 3xTG females, activational estrogens are 
believed to be neuroprotective against Alzheimer’s pathology. Ovariectomy-induced depletion of sex hormones 
in 3xTG females increases Aβ accumulation and impairs HPC-dependent memory, an effect that can be atten-
uated by estrogen treatment42–45. It is also possible that differences in male and female longevity contributed to 
sex differences in 3xTG mice, since 3xTG females have a longer lifespan than males46. This sex difference was not 
observed in 5xFAD mice at this age, where a more aggressive amyloid pathology may block the beneficial effects 
of estrogens in easier testing conditions.
Object location memory was impaired across sex and AD strain, suggesting that spatial processing of objects 
may be more difficult for AD mice than the processing of object identity. Impaired OL memory is consistent 
with previous work17,33,47–49, and as OL is a HPC-dependent task this finding provides additional support for 
susceptibility of HPC-dependent processes to AD pathology. Since Wt males for the 3xTG strain had difficulty 
performing the OL task, it is possible that some OL deficits in males may be related to general aging rather than 
AD. Indeed, OL is often impaired in aged mice50,51.
Multisensory integration (MSI) is a relatively neglected facet of cognition in AD, despite findings from 
patients demonstrating abnormal MSI31,32. Multisensory integration involves the binding of information across 
sensory modalities, which can require connectivity of modality-specific sensory processing areas52,53. Given the 
disruption of cortical connectivity in human patients54,55 and APP/PS1 mice56, impaired connectivity between 
cortical regions may impair binding of visual and tactile object information. The current results represent the 
first demonstration of impaired MSI in rodent models of AD. While 5xFAD female and 3xTG mice show a selec-
tive deficit on tactile-visual MSO, 5xFAD and Wt male mice from the same background also had impairments 
in unimodal tactile and visual object oddity tasks. Unimodal tactile and visual object oddity performance also 
informs the interpretation of results from object memory tasks, in which mice must also encode object features 
perceptually. 5xFAD mice display delay-independent impairments on all mnemonic object tasks and 5xFAD 
males have impairments on tactile and visual oddity; therefore, impaired OR and OL in 5xFAD males could be 
most parsimoniously attributed to deficits in object perception rather than memory. Again, the impairment in 
5xFAD Wt males may be related to accelerated aging or other abnormalities in the 5xFAD background strain. 
Conversely, 5xFAD females and 3xTG mice had selective multisensory oddity impairments, with spared uni-
modal perception; thus, it is unlikely that OR and OL impairments can be explained by perceptual deficits. In this 
case, the object test battery approach provides a great advantage over standard testing methods in this field by 
strengthening the conclusions that can be drawn about specific cognitive impairments.
Atypical motor and anxiety-like behaviours have been reported in both 5xFAD and 3xTG strains. Aged 
3xTG mice have increased anxiety-like behaviours including increased restlessness, startle responses, and freez-
ing23,57–59, whereas motor behaviour is more complex with accounts of hypoactivity59 or normal locomotion in the 
open-field23, as well as enhanced performance on other motor tasks16,24. Conversely, 5xFAD mice have reduced 
anxiety-like behaviours and motor deficits60,61. However, there were no consistent differences between genotypes 
or sex in terms of general object exploratory behaviour in any of the tests used; thus, it is unlikely that gross 
changes to motor or anxiety-related behaviors significantly impacted the current findings.
Abnormalities in several proteins associated with AD were seen in both 5xFAD and 3xTG mice. A pattern 
of amyloid deposition that is more severe in the HPC than cortex was observed in both mouse strains. 5xFAD 
mice have much more Aβ42 deposition than 3xTG mice, consistent with multiple APP and PS1 mutations act-
ing in an additive fashion to accelerate amyloid deposition and cognitive impairment in the former62. While 
Aβ42 likely contributes to the observed cognitive impairments, especially in HPC-dependent object tasks, Aβ42 
deposition is minimal in 3xTG mice at this advanced age. Indeed, Aβ42 was not elevated in the cortex or HPC 
of 3xTG males. However, we did detect increased levels of total Aβ, suggesting that 3xTG males may have dif-
ferent proportions of Aβ 37, 38, 39, 40, and 42 at 12-months-of-age. Despite the lack of robust changes in Aβ42, 
we have demonstrated significant behavioural impairments in male 3xTG mice, highlighting the importance of 
other pathological changes on behavioural phenotypes. Both strains had abnormalities in tau phosphorylation 
and astrogliosis, other pathological hallmarks of AD associated with cognitive impairment63,64. Consistent with 
previous observations we report elevations in tau phosphorylation in both 5xFAD65–67 and 3xTG42,68–71 mice, with 
novel strain, sex, and regional differences on phosphorylation at specific tau residues. Extensive gliosis (GFAP) 
was also observed in both 5xFAD62,72 and 3xTG68–70,73 mice, also with interesting differences between strain, sex 
and brain region. Paradoxically, PSD-95 was elevated in 5xFAD and 3xTG females which may result from the loss 
of PSD-95 at apical dendrites but accumulation in cell bodies in advanced AD74. Contrary to the existing litera-
ture75, ChAT was also elevated in 3xTG females and may reflect a compensatory response as female sex hormones 
can modulate AD pathology and cholinergic neurotransmission42,76. The opposite pattern was observed for ChAT 
in 5xFAD mice77.
The current study illustrates the subtle but potentially clinically significant differences in behavioural char-
acterization possible when using a testing battery to probe different aspects of object information processing, 
not just “object recognition” as defined by the most commonly chosen task. We recommend such a systematic 
approach moving forward to better evaluate the cognitive phenotypes of transgenic models, as well as potential 
therapeutic interventions, in this context.
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Methods
Animals. 5xFAD wild-type (B6SJLF1/J; male n = 20, female n = 33) and transgenic (B6SJLTg(APPSwF1Lon, 
PSEN1*M146L*L286V)6799Vas/Mmjax; male n = 23, female n = 33) mice and 3xTG wild-type (B6129SF2/J; 
male n = 24, female n = 35) and transgenic (B6;129Psen1tm1Mpm Tg(APPSwe, tauP301L)1Lfa/Mmjax; male n = 21, 
female n = 35) mice were obtained from Jackson Laboratory (Bar Harbor, USA). Because we were primarily com-
paring WT and TG mice, there was no random assignment to groups. A minimum of 7 mice per group were used 
for behavioural experiments; our previous work indicates power of 0.80 can be achieved with a sample size of 6 
mice (α = 0.05). Differences in sample sizes between sexes was a result of attrition46. Mice were housed in poly-
ethylene cages (16 × 12 × 26 cm) with corncob bedding, crink-l’Nest and cotton nest squares and food (Tekland 
Global 16% Protein Rodent Maintenance Diet, Harlan Tekland, USA) and water available ad libitum. Mice were 
tested during the light phase of a 12 h light/dark cycle (0800 lights on; 2000h lights off). All procedures followed 
the guidelines of the Canadian Council on Animal Care and were approved by the Animal Care Committee at the 
University of Guelph and the University of Western Ontario (2006-103 and 2006-104). Object recognition testing 
started when mice were 12 months of age after they were tested in different touchscreen tasks.
Object-based Memory Tasks. Object recognition was run in a modified Y-apparatus with walls 30.5 cm 
high, and arms 15 cm long and 7 cm wide constructed from white Plexiglas (Fig. 1a). The start arm of the 
Y-apparatus has a guillotine door 11 cm from the back of the arm that was closed at the beginning of each trial. 
When OR is conducted in the Y-apparatus, spatial information is minimized, allowing for direct evaluation of 
object identity processing37. Objects were visually and tactually distinct, approximately 5–15 cm in height and 
3–6 cm wide, made of glass, metal or plastic and were previously found to produce no obvious preference biases 
in mice. In the sample phase, mice were presented two identical objects to explore for 10 min. Following the sam-
ple phase, there was a 5-min or 3-h retention delay, to assess short- and long-term memory, respectively. At the 
end of the retention delay, mice underwent a 2-min choice phase, in which mice were presented with one object 
from the sample phase and a novel object. Object recognition was also evaluated with the same parameters in a 
square open-field arena (45 × 45 × 30 cm) made of white corrugated plastic (Fig. 1b). When OR is evaluated in 
the open-field, spatial and contextual cues in the testing room are readily available; this task might therefore be 
more hippocampus-dependent than Y-apparatus OR37. In both OR tasks, the order of object pairs, the designated 
sample and choice novel object within each pair, and the side of the apparatus (left or right) where the novel object 
was placed during the choice phase were counterbalanced. The object location task was used to evaluate spatial 
object memory in the open-field using the same testing parameters as OR, except that one object from the sample 
phase was moved to an adjacent corner of the arena in the choice phase (Fig. 1c); in this case, the location of one 
object, rather than its identity, is novel. In OL, the order of object pairs and the side of the apparatus (left or right) 
where the novel object was placed during the choice phase were counterbalanced. For all object memory tasks, the 
novelty preference was quantified by calculating a discrimination ratio (DR = (novel object exploration – famil-
iar object exploration)/(total object exploration)). Repeated measures ANOVAs were used to analyze DRs with 
retention delay as a within-subjects factor and sex and genotype as between-subjects factors. Where appropriate, 
post-hoc t-tests were used to analyze group differences. In the sample phase, objects should be equally novel 
and a DR of approximately zero is expected. In the choice phase, a DR significantly greater than zero indicates 
novelty preference, from which we infer intact memory. Paired samples t-tests were used to compare sample and 
choice DRs, as a significant increase in the DR from sample to choice is indicative of intact memory. Outliers 
(>2 SD ± mean; 33 data points total) and mice that spent less than 3% of the choice phase exploring78 (19 data 
points) were excluded. General exploratory measures are reported in Supplementary Tables 3 and 4.
Perceptual Object Oddity Tasks. Oddity tasks were run in a modified trapezoid-like open-arena (front 
wall 39 cm, side walls 14 cm, angled side walls 10 cm, back wall 28 cm; Fig. 2a). In MSO, mice explored two pairs 
of objects that shared combinations of tactile and visual features (e.g., AB/AB and CD/CD), as well as a dissim-
ilar object that comprised a unique (i.e. ‘odd’) combination of those features (e.g., BC) for 10 min. Tactile object 
features were manipulated using varieties of sandpaper with different grades, while visual object features were 
manipulated using 2-D stickers with distinctive visual markings. Unimodal control trials were also run according 
to the same format, except the objects were distinguished by configurations of features from within the same 
sensory modality (i.e., visual or tactile)52. Placement of the ‘odd’ object was counterbalanced across trials and 
experiments.
An oddity preference for the ‘odd’ object was calculated (OP = (exploration of the odd object)/(total object 
exploration)). Repeated measures ANOVAs were used to analyze OPs with task as a within-subjects factor and 
genotype as a between-subjects factor. Where appropriate, post-hoc t-tests were used to analyze between group 
differences. With five objects, an OP significantly greater than 0.2 (‘chance’) indicates an oddity preference, from 
which we infer intact perceptual discrimination; this analysis was performed using one sample t-tests. Outliers 
(>2 SD ± mean) and mice that spent less than 3% of the sample phase exploring were excluded.
General Behavioural Procedure. All behavioural testing was conducted under white fluorescent light in 
a 190 cm by 145 cm room with white walls and an orange door. A television, computer modem, and computer 
monitor sat atop metal shelving. A few additional visual cues were fixed to the walls. The apparatuses were placed 
on the floor away from the walls.
Prior to behavioural testing all mice were extensively handled and habituated to an empty testing apparatus 
for 10 min on two consecutive days. Behavioural testing began at least 24 h after the second habituation day. 
Immediately prior to testing, mice were brought into the testing room in their home cage. Mice were placed 
in either the start arm of the Y-apparatus or in a start box placed in the center of the open field. The trial began 
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when the start arm/box was opened or removed, respectively, and the mouse began to explore. During testing, an 
experimenter blind to the experimental condition, viewed the mouse on a television screen and pressed a key cor-
responding to a given object at the onset and end of an exploratory bout (sniffing within 1 cm of the object and/
or touching the object with the nose). Between trials, objects were wiped with 50% ethanol (to eliminate olfactory 
cues), the testing apparatus was wiped with dry paper towel and the mouse was returned to its home cage.
Western Blots and ELISA. Immediately after behavioural testing (~13 months of age), cortices and hip-
pocampi were homogenized in Triton X-100 lysis buffer containing 1 mM 4-(2-aminoethyl)benzenesulfonyl flu-
oride hydrochloride, 10 μM leupeptin, 25 μM aprotinin, 10 μM pepstatin A, and 700 units DNase. Lysate protein 
concentrations were determined using a Bradford assay.
Total Aβ (37, 38, 39, 40, 42), phospho-tau, total tau, NeuN, postsynaptic density (PSD)-95, glial fibrillary 
acidic protein (GFAP), and choline acetyltransferase (ChAT) levels were evaluated using Western blot analysis. 
For western blots protein samples (25 μg/well) were run on 10% SDS-PAGE using a Mini-PROTEAN Tetra cell 
system. Samples were transferred to nitrocellulose membranes, blocked in 3% BSA (Fisher Scientific; with or 
without milk) in tris-buffered saline 0.1% Tween20 (TBS-T) for 1.5 h, and incubated in primary antibodies over-
night (see Supplementary Table 1). Blots were subsequently rinsed with TBS-T, incubated in secondary antibody 
in BSA, rinsed with TBS-T, and visualized using Luminata Forte chemi solution and the ChemiDoc MP imaging 
system. Densitometry was performed using Image Labv4.1 software comparing levels of each target to α-tubulin. 
To account for variability between blots the densitometric value for each individual protein band was expressed 
as a fraction of the total amount of that protein on the same blot. Each protein of interest was normalized to 
α-tubulin values from the same sample and the normalized protein levels in the transgenic mice were presented 
as the fold change relative to values from the Wt mice from the same blot. Two-way ANOVAs were used to 
analyze genotype and sex effects on each target protein. Log (x + 1) transformations were performed to address 
heterogeneity of variance.
ELISA measurements of Aβ42 were conducted using the standard or ultrasensitive amyloid beta 42 human 
ELISA kits from ThermoFisher Scientific for 5xFAD and 3xTG lysates, respectively. Three-way ANOVAs were 
used to analyze strain, genotype and sex effect on Aβ42.
Statistical Analysis. All statistical analyses were performed with α = 0.05 using SPSS. Where appropriate, 
the Bonferroni correction was applied. All data met assumptions of normality and homogeneity.
Data Availability
The datasets generated and analysed during the current study are available from the corresponding author on 
reasonable request.
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